Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway - Direct cross-talk between phase I and II drug-metabolizing enzymes

被引:438
作者
Miao, WM
Hu, LG
Scrivens, PJ
Batist, G
机构
[1] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal Ctr Expt Therapeut Canc, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1074/jbc.M412081200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aryl hydrocarbon receptor (AHR) and NF-E2 p45-related factor (NRF2) are two distinct transcription factors involved in the regulation of drug-metabolizing enzymes. Increasing evidence from several studies implies that AHR and NRF2 have direct links, but the molecular mechanism remains unknown. In this work we demonstrate for the first time that Nrf2 gene transcription is directly modulated by AHR activation. DNA sequence analyses of the mouse Nrf2 promoter revealed one xenobiotic response element (XRE)-like element (XREL1) located at -712 and two additional XRE-like elements located at +755 (XREL2) and +850 (XREL3). Functional analysis using luciferase assay showed that XREL1, XREL2, and XREL3 are all inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment, with XREL2 being the most potent. The functionality of these XRE-like elements was further confirmed by mutagenesis and gel shift experiments. Finally, we used chromatin immuno-precipitation assay to show a direct binding of AHR to the Nrf2 promoter. Cells with silenced AHR expression using siRNA also lost NRF2 mRNA induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin. These new data position NRF2- antioxidant response element downstream in the AHR-XRE pathway. Moreover, direct regulation of NRF2 by AHR contributes to couple phase I and II enzymes into an integrated system facilitating more effective xenobiotic and carcinogen detoxification.
引用
收藏
页码:20340 / 20348
页数:9
相关论文
共 40 条
[1]   Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression [J].
Bloom, DA ;
Jaiswal, AK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44675-44682
[2]   NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development [J].
Chan, KM ;
Lu, RH ;
Chang, JC ;
Kan, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13943-13948
[3]  
DENISON MS, 1988, J BIOL CHEM, V263, P17221
[4]   Identification of a purine-rich intronic enhancer element in the mouse eosinophil-associated ribonuclease 2 (mEar 2) gene [J].
Dyer, KD ;
Nitto, T ;
Moreau, JM ;
McDevitt, AL ;
Rosenberg, HF .
MAMMALIAN GENOME, 2004, 15 (02) :126-134
[5]  
FAVREAU LV, 1991, J BIOL CHEM, V266, P4556
[6]   REGULATION OF CYP1A1 EXPRESSION [J].
FUJIIKURIYAMA, Y ;
IMATAKA, H ;
SOGAWA, K ;
YASUMOTO, KI ;
KIKUCHI, Y .
FASEB JOURNAL, 1992, 6 (02) :706-710
[7]   Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention [J].
Hayes, JD ;
McMahon, M .
CANCER LETTERS, 2001, 174 (02) :103-113
[8]   Translational strategies for cancer prevention in liver [J].
Kensler, TW ;
Qian, GS ;
Chen, JG ;
Groopman, JD .
NATURE REVIEWS CANCER, 2003, 3 (05) :321-329
[9]   YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders [J].
Klenova, E ;
Scott, AC ;
Roberts, J ;
Shamsuddin, S ;
Lovejoy, EA ;
Bergmann, S ;
Bubb, VJ ;
Royer, HD ;
Quinn, JP .
JOURNAL OF NEUROSCIENCE, 2004, 24 (26) :5966-5973
[10]   Increased arythydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer [J].
Koliopanos, A ;
Kleeff, J ;
Xiao, Y ;
Safe, S ;
Zimmermann, A ;
Büchler, MW ;
Friess, H .
ONCOGENE, 2002, 21 (39) :6059-6070